Marshall Wace
SGTX

Marshall Wace’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Marshall Wace’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-290
Closed -$10K – 3835
2021
Q4 		$10K Buy
+290
New +$10K ﹤0.01% 3049